Home Cart 0 Sign in  
X

[ CAS No. 86499-96-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 86499-96-9
Chemical Structure| 86499-96-9
Chemical Structure| 86499-96-9
Structure of 86499-96-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 86499-96-9 ]

Related Doc. of [ 86499-96-9 ]

Alternatived Products of [ 86499-96-9 ]

Product Details of [ 86499-96-9 ]

CAS No. :86499-96-9 MDL No. :MFCD03085918
Formula : C10H10BrNO Boiling Point : -
Linear Structure Formula :- InChI Key :JMXPGCGROVEPID-UHFFFAOYSA-N
M.W : 240.10 Pubchem ID :2757184
Synonyms :

Calculated chemistry of [ 86499-96-9 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.3
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 59.22
TPSA : 29.1 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.12 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.86
Log Po/w (XLOGP3) : 2.32
Log Po/w (WLOGP) : 1.76
Log Po/w (MLOGP) : 2.19
Log Po/w (SILICOS-IT) : 2.58
Consensus Log Po/w : 2.14

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.13
Solubility : 0.177 mg/ml ; 0.000738 mol/l
Class : Soluble
Log S (Ali) : -2.57
Solubility : 0.647 mg/ml ; 0.00269 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.08
Solubility : 0.0202 mg/ml ; 0.0000841 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.56

Safety of [ 86499-96-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302+H312+H332-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 86499-96-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 86499-96-9 ]
  • Downstream synthetic route of [ 86499-96-9 ]

[ 86499-96-9 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 4424-80-0 ]
  • [ 86499-96-9 ]
YieldReaction ConditionsOperation in experiment
70.1%
Stage #1: With phosphorus pentachloride; iodine In chloroform at 0℃; for 0.5 h;
Stage #2: With bromine In chloroform at 0 - 20℃; for 4 h; Refluxed
A solution of Part A(1) compound (1.0 g, 6.20 mmoles) in dry CHCl3 (15 ml) was cooled down to 0° C. (ice-salt bath), treated with PCl5 (1.5 g, 7.20 mmoles) followed by I2 (15 mg) then stirred at 0° C. under argon for 30 minutes. The yellow solution was treated with Br2 (0.39 ml or 1.2 g, 7.51 mmoles), warmed up to room temperature and refluxed under argon for 4.0 hours. The mixture was then poured into ice-water (20 g), stirred and the phases were separated, washing the aqueous phase with CHCl3 (25 ml). The combined organic extracts were washed with H2O (5.0 ml), dried (anhydrous MgSO4), filtered, evaporated to dryness and dried in vacuo. The crude product mixture was chromatographed on a silica gel column (Merck, 70 g), eluting the column with EtOAc:Hexane (1:9) to give title compound as off-white precipitates (1.137 g., m.pt. 170-172°, 70.1percent) with consistent 1H-NMR and 13C-NMR spectral data. [00180] TLC: Rf 0.13 (Silica gel; EtOAc:Hexane-1:4; UV).
Reference: [1] Patent: US6777550, 2004, B1, . Location in patent: Page column 28
[2] Patent: US4575503, 1986, A,
[3] Patent: US4410520, 1983, A,
[4] Patent: US4473575, 1984, A,
[5] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 17, p. 3488 - 3494
  • 2
  • [ 56384-59-9 ]
  • [ 86499-96-9 ]
YieldReaction ConditionsOperation in experiment
98%
Stage #1: at 60℃; for 20 h;
10 parts by weight of the heated melted polyphosphoric acid was added to the drying kettle, With stirring, The above 2-bromo-3,4-dihydro-N-hydroxy- (2H) -naphthalimide was added in portions at a temperature of 60 ° C, Insulation reaction for 20 hours; The reaction solution was added dropwise to 12.5 parts by weight of water to carry out hydrolysis, Still Washed to give 3-bromo-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one crude; 10 parts by weight of methanol and 0.1 part by weight of activated carbon were added, Heating decolorization, After filtration, the filtrate was cooled to 10 ° C for 20 hours, centrifuged, washed and dried to give 3-bromo-1,3,4,5-tetrahydro-2H-1-benzazepan-2-one. The purity of the product was 3, 10-bromo-1,3,4,5-tetrahydro-2H-1-benzazepan-2-one as high as 99.6percent and the yield was as high as 98percent.
Reference: [1] Patent: CN105017154, 2017, B, . Location in patent: Paragraph 0032; 0050-0051; 0056-0057
[2] Journal of Heterocyclic Chemistry, 1994, vol. 31, # 6, p. 1545 - 1552
[3] Patent: US5677297, 1997, A,
  • 3
  • [ 529-34-0 ]
  • [ 86499-96-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 17, p. 3488 - 3494
[2] Patent: CN105017154, 2017, B,
  • 4
  • [ 1056246-70-8 ]
  • [ 86499-96-9 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1994, vol. 31, # 6, p. 1545 - 1552
  • 5
  • [ 71-43-2 ]
  • [ 86499-96-9 ]
Reference: [1] Patent: CN105017154, 2017, B,
  • 6
  • [ 86499-96-9 ]
  • [ 109010-60-8 ]
Reference: [1] Journal of Organic Chemistry, 1997, vol. 62, # 23, p. 8271 - 8272
  • 7
  • [ 86499-96-9 ]
  • [ 86499-35-6 ]
Reference: [1] Organic and Biomolecular Chemistry, 2012, vol. 10, # 47, p. 9474 - 9480
[2] Patent: US2002/183324, 2002, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 86499-96-9 ]

Bromides

Chemical Structure| 3279-90-1

[ 3279-90-1 ]

6-Bromo-3,4-dihydro-1H-quinolin-2-one

Similarity: 0.76

Chemical Structure| 316146-27-7

[ 316146-27-7 ]

N-(4-Bromophenyl)-3-phenylpropanamide

Similarity: 0.74

Chemical Structure| 880094-83-7

[ 880094-83-7 ]

5-Bromo-3,4-dihydroquinolin-2(1H)-one

Similarity: 0.74

Chemical Structure| 14548-51-7

[ 14548-51-7 ]

7-Bromo-3,4-dihydroquinolin-2(1H)-one

Similarity: 0.72

Chemical Structure| 129722-34-5

[ 129722-34-5 ]

7-(4-Bromobutoxy)-3,4-dihydroquinolin-2(1H)-one

Similarity: 0.71

Amides

Chemical Structure| 22246-76-0

[ 22246-76-0 ]

8-Amino-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one

Similarity: 0.81

Chemical Structure| 22246-07-7

[ 22246-07-7 ]

7-Amino-3,4-dihydro-2(1H)-quinolinone

Similarity: 0.79

Chemical Structure| 553-03-7

[ 553-03-7 ]

3,4-Dihydroquinolin-2(1H)-one

Similarity: 0.76

Chemical Structure| 22246-13-5

[ 22246-13-5 ]

6-Amino-3,4-dihydroquinolin-2(1H)-one

Similarity: 0.76

Chemical Structure| 4424-80-0

[ 4424-80-0 ]

4,5-Dihydro-1H-benzo[b]azepin-2(3H)-one

Similarity: 0.76

Related Parent Nucleus of
[ 86499-96-9 ]

Other Aromatic Heterocycles

Chemical Structure| 22246-76-0

[ 22246-76-0 ]

8-Amino-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one

Similarity: 0.81

Chemical Structure| 4424-80-0

[ 4424-80-0 ]

4,5-Dihydro-1H-benzo[b]azepin-2(3H)-one

Similarity: 0.76

Chemical Structure| 86499-35-6

[ 86499-35-6 ]

3-Amino-2,3,4,5-tetrahydro-1H-benzazepin-2-one

Similarity: 0.75

Chemical Structure| 209984-30-5

[ 209984-30-5 ]

5-Methyl-5H-dibenzo[b,d]azepin-6(7H)-one

Similarity: 0.75

Chemical Structure| 1015-89-0

[ 1015-89-0 ]

Phenanthridin-6(5H)-one

Similarity: 0.71